Vaccination against human papillomavirus
Relevant BNF section: 14.4
Anogenital infection with human papillomavirus (HPV) is a common sexually transmitted disease that can result in genital warts, anogenital intraepithelial neoplasia or, occasionally, anogenital carcinoma.1,2 HPV infection is now recognised as a prerequisite for the development of cervical cancer.1 Therefore, the availability of vaccines against HPV and the introduction of national HPV vaccination programmes in several countries, including the UK, represent an important new development in cancer prevention strategies. Here we review the two licensed HPV vaccines and discuss the implications of the UK programme.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
-
Infections
-
Malignant disease and immunosuppression
-
Infectious diseases
-
Oncology
-
Immunology (including allergy)
Bookmark with
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
